HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CHPA initiates search for president

This article was originally published in The Rose Sheet

Executive Summary

Consumer Healthcare Products Association is commencing search for a new president after Michael Maves, MD, was appointed to head American Medical Association Nov. 19. Maves will take over as AMA exec VP/CEO effective Jan. 15, departing CHPA after two years. Maves took the helm at CHPA not long after OTC trade group, formerly known as Nonprescription Drug Manufacturers Association, expanded its membership to include dietary supplement companies...

You may also be interested in...

CHPA interim president?

Consumer Healthcare Products Association reportedly offered board member and healthcare consultant Robert Donovan position of interim president. Donovan, who heads consultancy firm Robert Donovan LLC, formerly led consumer pharmaceuticals business at Sandoz Pharmaceuticals and also worked in consumer products division at Pfizer. He was first elected to CHPA board in 1990. If Donovan accepts, he will succeed Michael Maves, MD, who will leave the association Jan. 15 to head American Medical Association (1"The Rose Sheet" Nov. 26, In Brief)...

Basilea Stresses Derazantinib's FGFR Kinase Differentiation

Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.


ATMPs Put EU Cross-Border Healthcare On The Map

Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts